Phthalylsulfathiazole
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.001.480 |
Chemical and physical data | |
Formula | C17H13N3O5S2 |
Molar mass | 403.43 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Phthalylsulfathiazole (also known as sulfathalidine) belongs to the group of drugs called sulfonamides. The drug is a broad-spectrum antimicrobial that can treat different types of infections including intestinal. The mechanism of action depends on competitive antagonism with para-aminobenzoic acid and inhibition of dihydropteroate synthetase activity, which in turn leads to impaired synthesis of dihydrofolic acid and as a result its active metabolite necessary for the synthesis of purine and pyrimidine.
The drug is indicated in the treatment of dysentery, colitis, gastroenteritis and intestinal surgery. It is not absorbed into the blood stream from the gut due to extra n⁴ substitute. Adverse effects may include allergic reactions, vitamin B insufficiency, agranulocytosis and aplastic anemia.